Assessing anti-inflammatory and neutrophil-modulating capacity of phage therapy for Pseudomonas aeruginosa infection - Copy of 2022/GR001499

Project Details

StatusActive
Effective start/end date3/06/23 → 1/12/25

Funding

  • Vertex Pharmaceuticals (Aust) Pty Ltd: A$180,000.00